Walgreens Suspends Dividend: A New Chapter in Its Financial Journey
Friday, Jan 31, 2025 8:31 am ET
Walgreens Boots Alliance (WBA) has made a significant move by suspending its quarterly cash dividend, marking the end of a 90-plus year streak of shareholder payouts. This decision, announced on Thursday, January 31, 2025, is a strategic shift aimed at strengthening the company's balance sheet and improving its financial health. The company's cash needs over the next several years, including with respect to litigation and debt refinancing, were key considerations in the decision to suspend the dividend.

The suspension of the dividend is expected to help Walgreens reduce debt over time and improve free cash flow. The company estimates that this move will save it about $650 million in fiscal year 2025 and as much as $850 million in fiscal year 2026. This decision comes as Walgreens faces several challenges, including industry-wide competition, pricing pressure from pharmacy benefit managers, and billions invested into a money-losing health care strategy that has loaded it up with debt.
payout ratio(6525)dividend yield(6144)payout ratio;dividend yield(6144)
Payout Ratio%2024.12.31 | Dividend Yield (TTM)%2025.01.29 |
---|---|
-- | 0.66 |
-- | -- |
-- | 0.96 |
-- | -- |
-- | -- |
-- | -- |
-- | -- |
-- | 1.18 |
-- | -- |
-- | 0.29 |
Ticker |
---|
AAgilent Technologies |
AACGAta Creativity |
AAAlcoa |
AACTAres Acquisition II |
AACT.UAres Acquisition-U |
AADIAadi Bioscience |
AALAmerican Airlines |
AAMEAtlantic American |
AAMAA Mission |
AAONAaon |
View 6144 results
Walgreens' decision to suspend its dividend is a clear indication of the company's commitment to addressing its financial challenges and refocusing on its long-term growth and turnaround strategy. The company has been on a mission to right-size itself and boost its market value under CEO Tim Wentworth, who took over in October 2023. Moves have included closing hundreds of stores and laying off employees, but despite these efforts, Walgreens still posted a $265 million net loss in the first quarter of 2025.
The suspension of the dividend is likely to have an impact on Walgreens' shareholder base, with some investors potentially selling their shares due to the reduced income. However, analysts like Elizabeth Anderson from Evercore ISI Group view this move as a positive step in Walgreens' turnaround strategy. Anderson estimates that the dividend suspension will save Walgreens about $650 million in fiscal year 2025 and as much as $850 million in fiscal year 2026.
In conclusion, Walgreens' decision to suspend its dividend is a strategic move aimed at improving the company's financial health and long-term growth prospects. By reducing its dividend payout, Walgreens can allocate more resources towards addressing its legal issues, refinancing its debt, and investing in its turnaround strategy. This decision is expected to have both short-term and long-term consequences for the company and its shareholders, but ultimately, it is a step towards a more stable and prosperous future for Walgreens Boots Alliance.